FLEMINGTON, N.J.--(BUSINESS WIRE)--Jan. 12, 2006--NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company with an oral spray technology applicable to a broad range of therapeutic areas and product categories, will be presenting at the 2006 Arch Investor Conference on January 19, 2006 at 9:15 AM. The conference is being held in New York City at the Hotel Plaza Athenee, at 37 East 64th Street. Dr. Jan Egberts, NovaDel’s Chief Executive Officer, will provide a corporate overview, including an update on NovaDel’s product pipeline. NovaDel’s novel drug delivery system provides a number of potential benefits, including faster onset of action. All of the product candidates could qualify for the fast-track 505(b)(2) regulatory approval path.
